| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Travere Therapeutics Inc (NASDAQ: TVTX)
TVTX Technical Analysis
5
| As on 9th Jun 2023 TVTX STOCK Price closed @ 16.67 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 25.51 & Strong Sell for SHORT-TERM with Stoploss of 27.87 we also expect STOCK to react on Following IMPORTANT LEVELS. |
TVTXSTOCK Price
| Open | 16.63 | Change | Price | % |
| High | 17.10 | 1 Day | 0.00 | 0.00 |
| Low | 16.45 | 1 Week | 0.25 | 1.52 |
| Close | 16.67 | 1 Month | -4.32 | -20.58 |
| Volume | 1266908 | 1 Year | -13.09 | -43.99 |
| 52 Week High 31.17 | 52 Week Low 15.65 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| TVTX Daily Charts |
TVTX Intraday Charts |
Whats New @ Bazaartrend |
TVTX Free Analysis |
|
|
TVTX Important Levels Intraday
| RESISTANCE | 17.92 |
| RESISTANCE | 17.52 |
| RESISTANCE | 17.27 |
| RESISTANCE | 17.02 |
| SUPPORT | 16.32 |
| SUPPORT | 16.07 |
| SUPPORT | 15.82 |
| SUPPORT | 15.42 |
TVTX Forecast May 2024
| 4th UP Forecast | 30.43 |
| 3rd UP Forecast | 26.02 |
| 2nd UP Forecast | 23.29 |
| 1st UP Forecast | 20.56 |
| 1st DOWN Forecast | 12.78 |
| 2nd DOWN Forecast | 10.05 |
| 3rd DOWN Forecast | 7.32 |
| 4th DOWN Forecast | 2.91 |
TVTX Weekly Forecast
| 4th UP Forecast | 20.70 |
| 3rd UP Forecast | 19.41 |
| 2nd UP Forecast | 18.61 |
| 1st UP Forecast | 17.81 |
| 1st DOWN Forecast | 15.53 |
| 2nd DOWN Forecast | 14.73 |
| 3rd DOWN Forecast | 13.93 |
| 4th DOWN Forecast | 12.64 |
TVTX Forecast2024
| 4th UP Forecast | 49.7 |
| 3rd UP Forecast | 39.11 |
| 2nd UP Forecast | 32.56 |
| 1st UP Forecast | 26.01 |
| 1st DOWN Forecast | 7.33 |
| 2nd DOWN Forecast | 0.78 |
| 3rd DOWN Forecast | -5.77 |
| 4th DOWN Forecast | -16.36 |
Travere Therapeutics Inc ( NASDAQ USA Symbol : TVTX )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
TVTX Business Profile
Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, and commercialization of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in well-opacifying gallbladders; Cholbam, a cholic acid capsule to treat pediatric and adult patients with bile acid synthesis disorders due to single enzyme defects, as well as for adjunctive treatment of patients with peroxisomal disorders; and Thiola and Thiola EC, a tiopronin tablet for the treatment of homozygous cystinuria. The company's product candidates also consist of Sparsentan, which is in Phase III clinical trial for the treatment of focal segmental glomerulosclerosis and immunoglobulin A nephropathy; and TVT-058, a novel investigational human enzyme replacement candidate, which is in Phase I/II clinical trials for the treatment of classical homocystinuria. It has a cooperative research and development agreement with National Institutes of Health's National Center for Advancing Translational Sciences, and Alagille Syndrome Alliance for identification of potential small molecule therapeutics for NGLY1 deficiency and Alagille syndrome. The company was formerly known as Retrophin, Inc. and changed its name to Travere Therapeutics, Inc. in November 2020. Travere Therapeutics, Inc. was incorporated in 2008 and is headquartered in San Diego, California. Address: 3611 Valley Centre Drive, San Diego, CA, United States, 92130
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service